79159531 - EXPRES2ION

Information

• Trademark
• 79159531

• Source

• Serial Number

  79159531

• Registration Number

  4893901

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 14, 2014
  10 years ago

• Registration Date

  February 02, 2016
  8 years ago

• Transaction Date

  March 20, 2023
  a year ago

• Status Date

  August 30, 2022
  a year ago

• Published for Opposition Date

  November 17, 2015
  8 years ago

• Location Date

  August 30, 2022
  a year ago

• Status Code

  739

• Current Location

  GENERIC WEB UPDATE

  Employee Name

  DESAI, BRIN ANDERSON

• Attorney Docket Number

  42972-113005

  Attorney Name

  George S. Pavlik

  Law Office Assigned Location Code

  M40

• Owners

  • Expres2ion Biotechnologies ApS

Case File Statements

• DM0000: The mark consists of the term "EXPRES2ION" where the "2" is displayed in superscript.
• GS0051: [ Chemicals and polymers for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; chemicals, namely, solid phases for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; ] insect cells, insect cell culture media and cell culture reagents all for medical use [ ; pharmaceutical preparations and substances and therapeutic pharmaceuticals for use in the diagnosis, prophylaxis and treatment of cancers, infectious diseases, autoimmune diseases, ophthalmological diseases, metabolic diseases, respiratory diseases, cardiovascular diseases, genetic diseases, and central nervous system conditions; preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body; biological and biochemical preparations for medical purposes for use in the diagnosis, prophylaxis and treatment of cancers, infectious diseases, autoimmune diseases, ophthalmological diseases, metabolic diseases, respiratory diseases, cardiovascular diseases, genetic diseases, and central nervous system conditions; microbiological and tissue culture media, animal blood and serum, and reagents and kits consisting of chemicals, biochemicals, and reagents, all for medical use; chemicals used for medical purposes, namely, reagents, proteins, cells, reagents containing proteins, ligands, effector molecules, and antibodies for medical use ]
• PM0001: EXPRESSION; EXPRES TWO ION
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Biological reagents for scientific and research purposes; biological and chemical preparations for use in biotechnology, namely, [ oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and ] reagents for use in genetic and proteomics research; [ chemicals and polymers other than for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; chemicals, namely, solid phases other than for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; ] reagents containing ligands, effector molecules and antibodies for scientific and medical research use; [ antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells; ] chemicals, biochemicals and reagents for use in industry, science and research; [ chemical compositions for scientific and industrial use in the preparation of culture media; media for cell/tissue cultures, cell/tissue culture growth supplements, reagents and buffers for use in cell/tissue cultures, transfection reagents, cryopreservation reagents other than for medical or veterinary purposes; ] reagents containing proteins, ligands, effector molecules and antibodies for scientific or medical research use; biological and biochemical preparations for scientific or medical research use, namely, [ oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and ] reagents for use in genetic and proteomics research; reagents and kits consisting of chemicals, biochemicals and reagents, all for scientific or research use; kits for scientific and research use consisting primarily of [ one or more of the following: proteins, nucleic acids, hormones, purification supports, resins, cells, gels, buffers, stains and associated ] reagents for the expression, amplification, purification and analysis of biological samples; protein and kits consisting primarily of [ oligonucleotides, peptide substrates, assays and ] reagents for use in genetic and proteomics research and for research purposes in biochemical laboratories; [ cell lines for use in scientific, laboratory, diagnostic and medical research; ] biological and chemical preparations for use in biotechnology, namely, [ oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and ] reagents for use in genetic and proteomics research; chemical and biological products for use in medical science, namely, [ oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and ] reagents for use in genetic and proteomics research; [ microbiological and tissue culture media, animal blood and serum, and reagents and kits consisting of chemicals, biochemicals, and reagents, all for scientific research; chemicals used for medical research purposes, namely, reagents containing proteins, ligands, effector molecules, and antibodies for medical research use; ] insect cells, insect cell culture media, and cell culture reagents all for medical laboratory use [ ; reagents and kits consisting of chemicals, biochemicals, and reagents, all for medical diagnostic laboratory use ]
• GS0421: [ Medical and scientific research; research and consultation services in the fields of pharmaceuticals, vaccines, medicine, biological sciences, immunotherapy, and medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; scientific medical laboratory services; research and development for vaccines and new immunotherapy products for others; scientific and technological services, namely, research and design in the fields of medical diagnostics, vaccines, and pharmaceuticals; industrial analysis and research services in the fields of medical diagnostics, vaccines, and pharmaceuticals; research and development services all relating to science; research and development services all relating to industry in the fields of medical diagnostics, vaccines, and pharmaceuticals; research and development services all relating to science; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical research or in biochemical research; ] laboratory research services in the field of gene cloning, gene expression, electrophoresis, protein purification and analysis, and protein interaction detection [ ; providing research data and other molecular biology information for molecular biology reagents and kits in the fields of science and research; scientific research and development; medical and scientific research in the field of molecular biology; biological research; biological cloning services; providing information on the subject of scientific research in the fields of biochemistry and biotechnology; scientific research in the fields of genetics and genetic engineering; biochemical research and development; chemical, biochemical, biological and bacteriological research and analysis; providing reagent sample testing and diagnostic services for others in the field of science and research related thereto; DNA screening for scientific purposes; genetic mapping for scientific purposes; genetic testing for scientific research purposes; providing scientific information via a web site that gives computer users the ability to upload and share video-based scientific protocols and other scientific-based videos; providing information in the field of molecular biology for scientific research purposes, also via on line searchable databases; providing scientific data in protein purification and analysis, and protein interaction detection; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers with prophylactic and/or therapeutic purposes; technical research and consultation services in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; research and development for new immunotherapy products for others; biopharmaceutical research and development; scientific medical laboratory testing and diagnostic services for scientific research purposes; scientific research, namely, developing customized insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; contract scientific laboratory services and related consulting focused primarily on protein expressions, cell line development, and biotechnology upstream production process development ]

Case File Event Statements

• 3/17/2023 - a year ago

  49 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 3/17/2023 - a year ago

  48 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR

• 3/17/2023 - a year ago

  47 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 3/17/2023 - a year ago

  46 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 3/17/2023 - a year ago

  45 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/30/2022 - a year ago

  44 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75

• 8/30/2022 - a year ago

  43 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A

• 8/16/2022 - a year ago

  42 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 3/15/2022 - 2 years ago

  41 - TEAS SECTION 71 & 15 RECEIVED Type: ES75

• 2/2/2021 - 3 years ago

  40 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 4/16/2020 - 4 years ago

  39 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 12/10/2018 - 5 years ago

  38 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/10/2018 - 5 years ago

  37 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 9/15/2016 - 7 years ago

  36 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 7/8/2016 - 7 years ago

  35 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/4/2016 - 8 years ago

  34 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 5/4/2016 - 8 years ago

  33 - FINAL DISPOSITION PROCESSED Type: FIMP

• 5/2/2016 - 8 years ago

  32 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 2/2/2016 - 8 years ago

  31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/20/2015 - 8 years ago

  30 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 11/17/2015 - 8 years ago

  29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/17/2015 - 8 years ago

  28 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/4/2015 - 8 years ago

  27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 11/4/2015 - 8 years ago

  26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 10/28/2015 - 8 years ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/14/2015 - 8 years ago

  24 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 10/8/2015 - 8 years ago

  23 - ASSIGNED TO LIE Type: ALIE

• 9/10/2015 - 8 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/8/2015 - 8 years ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/8/2015 - 8 years ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/8/2015 - 8 years ago

  19 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 7/7/2015 - 8 years ago

  18 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 7/7/2015 - 8 years ago

  17 - FINAL REFUSAL E-MAILED Type: GNFR

• 7/7/2015 - 8 years ago

  16 - FINAL REFUSAL WRITTEN Type: CNFR

• 6/12/2015 - 9 years ago

  15 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/12/2015 - 9 years ago

  14 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/12/2015 - 9 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/12/2015 - 9 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/12/2015 - 9 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/13/2015 - 9 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 2/24/2015 - 9 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 2/24/2015 - 9 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 2/24/2015 - 9 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/23/2015 - 9 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/23/2015 - 9 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/10/2015 - 9 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 2/6/2015 - 9 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/6/2015 - 9 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/5/2015 - 9 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR